Canada emerged front and center in the fight against the coronavirus on Wednesday as Health Canada approved Phase II clinical trials for a nitric oxide treatment shown to be 99% effective against COVID-19 developed by SaNOtize, an OurCrowd portfolio company based in Vancouver.
